BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10509317)

  • 1. Independent assessment supports a role for tamoxifen in breast cancer risk reduction.
    Oncology (Williston Park); 1999 Sep; 13(9):1211. PubMed ID: 10509317
    [No Abstract]   [Full Text] [Related]  

  • 2. Tamoxifen and raloxifene may benefit women at high risk for breast cancer.
    Rollins G
    Rep Med Guidel Outcomes Res; 2002 Jul; 13(14):1-2, 5. PubMed ID: 12518771
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemoprevention of breast cancer.
    Dalton RR; Kallab AM
    South Med J; 2001 Jan; 94(1):7-15. PubMed ID: 11213947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soy and breast cancer: the controversy continues.
    Martínez ME; Thomson CA; Smith-Warner SA
    J Natl Cancer Inst; 2006 Apr; 98(7):430-1. PubMed ID: 16595771
    [No Abstract]   [Full Text] [Related]  

  • 5. Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reduction.
    Melnikow J; Paterniti D; Azari R; Kuenneth C; Birch S; Kuppermann M; Nuovo J; Keyzer J; Henderson S
    Cancer; 2005 May; 103(10):1996-2005. PubMed ID: 15825209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoprevention of breast cancer.
    O'Regan RM
    Cancer Treat Res; 2000; 103():183-207. PubMed ID: 10948447
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemoprevention in postmenopausal women.
    Rastogi P
    Menopause; 2008; 15(4 Suppl):810-5. PubMed ID: 18596603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Another view of tamoxifen.
    Napoli M
    Am J Nurs; 2001 Apr; 101(4):33. PubMed ID: 11301681
    [No Abstract]   [Full Text] [Related]  

  • 9. Task force cautious about chemoprevention. Official guidelines are out about taking tamoxifen and raloxifene to prevent breast cancer. These drugs can help, but they aren't for everyone.
    Harv Womens Health Watch; 2002 Oct; 10(2):1-2. PubMed ID: 12393316
    [No Abstract]   [Full Text] [Related]  

  • 10. First do no harm: extending the debate on the provision of preventive tamoxifen.
    Will BP; Nobrega KM; Berthelot JM; Flanagan W; Wolfson MC; Logan DM; Evans WK
    Br J Cancer; 2001 Nov; 85(9):1280-8. PubMed ID: 11720461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical inquiries. Does tamoxifen prevent breast cancer?
    Meriwether RA; Easton BT
    J Fam Pract; 2001 Dec; 50(12):1023. PubMed ID: 11742599
    [No Abstract]   [Full Text] [Related]  

  • 12. Breast cancer risk reduction: what do we know and where should we go?
    Prout MN
    Medscape Womens Health; 2000; 5(5):E4. PubMed ID: 11113777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast carcinoma chemoprevention in the community setting. Estimating risks and benefits.
    Brewster AM; Christo DK; Lai H; Helzlsouer K
    Cancer; 2005 Mar; 103(6):1147-53. PubMed ID: 15674856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Researchers wonder why high-risk women are not taking chemoprevention drugs.
    Savage L
    J Natl Cancer Inst; 2007 Jun; 99(12):913-4. PubMed ID: 17565147
    [No Abstract]   [Full Text] [Related]  

  • 15. Breast Cancer Prevention Trial is a raging success.
    Med Manag Netw; 1998 May; 6(5):5-7. PubMed ID: 10182972
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemoprevention: drug pricing and mortality: the case of tamoxifen.
    Melnikow J; Kuenneth C; Helms LJ; Barnato A; Kuppermann M; Birch S; Nuovo J
    Cancer; 2006 Sep; 107(5):950-8. PubMed ID: 16865680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Breakthrough in breast cancer chemoprevention].
    Kahán Z; Thurzó L
    Orv Hetil; 2003 Mar; 144(13):597-603. PubMed ID: 12728784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folate and risk of breast cancer: a meta-analysis.
    Larsson SC; Giovannucci E; Wolk A
    J Natl Cancer Inst; 2007 Jan; 99(1):64-76. PubMed ID: 17202114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary prevention of breast cancer in women with an increased risk for breast cancer--a prospective, randomized, double-blind study (NSABP-P1 study)].
    Reichert D; Illiger HJ
    Strahlenther Onkol; 2000 Jan; 176(1):43-4. PubMed ID: 10650836
    [No Abstract]   [Full Text] [Related]  

  • 20. Breast cancer prevention with tamoxifen.
    Haden K; Santen R
    Lippincotts Prim Care Pract; 2000; 4(4):434-40. PubMed ID: 11261120
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.